These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23346559)

  • 1. Quotient Bioresearch complete £1.5 million expansion of bioanalytical research facilities.
    King G
    Bioanalysis; 2012 Nov; 4(22):2666. PubMed ID: 23346559
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioanalytical outsourcing: transitioning from Pharma to CRO.
    Hayes R
    Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
    [No Abstract]   [Full Text] [Related]  

  • 3. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioanalytical recession continues.
    Kissinger PT
    Bioanalysis; 2013 Oct; 5(20):2445-7. PubMed ID: 24138617
    [No Abstract]   [Full Text] [Related]  

  • 5. Analytical and bioanalytical assay challenges to support comparability studies for biosimilar drug development.
    Cai XY; Wake A; Gouty D
    Bioanalysis; 2013 Mar; 5(5):517-20. PubMed ID: 23425265
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioanalytical outsourcing models in pharmaceutical companies.
    Zimmer D
    Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
    [No Abstract]   [Full Text] [Related]  

  • 7. A wide angle view of biosimilars from a bioanalytical perspective.
    Oldfield P
    Bioanalysis; 2013 Mar; 5(5):533-5. PubMed ID: 23425269
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in bioanalytical method validation for biologically derived macromolecules (biosimilars) compared with small molecules (generics).
    Oldfield P
    Bioanalysis; 2011 Jul; 3(14):1551-3. PubMed ID: 21756087
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of bioanalytical outsourcing: a pharma perspective.
    Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of biological therapeutic agents and biosimilars.
    Phinney K
    Anal Bioanal Chem; 2014 Oct; 406(26):6539. PubMed ID: 25190012
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in bioanalytical assays for biosimilars.
    Wang X; Chen L
    Bioanalysis; 2014 Aug; 6(16):2111-3. PubMed ID: 25331854
    [No Abstract]   [Full Text] [Related]  

  • 12. Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars.
    Nicholson R; Lowes S; Caturla MC; Safavi A; Mamelak D; Islam R; Allinson J; Gouty D; Khan M; Lelacheur R; Shoup R; Martinez S; Dumont I; Zimmer J; Steffen R; Petrilla J; Awaiye K; Sheldon C; Turk D; Fast D; Kamerud J; Dinan A; Lin ZJ; Garofolo W; Tang D; Wright L; Lin J; Yamashita Y; Liu Y; Xu A; Hayes R; Bouhajib M; Levesque A; Gagnon-Carignan S; Harman J; Warren M; Karnik S; Cojocaru L; Reuschel S; Gonzalez P; Fatmi S; Vija J; Rock M; Malone M; Nowatzke W; Fang X
    Bioanalysis; 2012 Oct; 4(19):2335-42. PubMed ID: 23088460
    [No Abstract]   [Full Text] [Related]  

  • 13. Conference Report: Bioanalysis-related topics presented at the International Conference and Exhibition on Biowaivers and Biosimilars.
    Colletti KS
    Bioanalysis; 2013 Mar; 5(5):529-31. PubMed ID: 23425268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotech innovators jump on biosimilars bandwagon.
    Moran N
    Nat Biotechnol; 2012 Apr; 30(4):297-9. PubMed ID: 22491261
    [No Abstract]   [Full Text] [Related]  

  • 15. Particle sizing methods for the detection of protein aggregates in biopharmaceuticals.
    Khodabandehloo A; Chen DD
    Bioanalysis; 2017 Feb; 9(3):313-326. PubMed ID: 28098491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical outsourcing: the two sides of the medal.
    Zimmer D
    Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioanalytical challenges of biosimilars.
    Islam R
    Bioanalysis; 2014 Feb; 6(3):349-56. PubMed ID: 24471955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biosensors--future analytical technology?].
    Nystrand A
    Lakartidningen; 1991 Dec; 88(49):4265-8. PubMed ID: 1758232
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonclinical development of a biosimilar: the current landscape.
    O'Connor A; Rogge M
    Bioanalysis; 2013 Mar; 5(5):537-44. PubMed ID: 23425270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks.
    Hayes R; LeLacheur R; Dumont I; Couerbe P; Safavi A; Islam R; Pattison C; Cape S; Rocci M; Briscoe C; Cojocaru L; Groeber E; Silvestro L; Bravo J; Shoup R; Verville M; Zimmer J; Caturla MC; Khadang A; Bourdage J; Hughes N; Fatmi S; Di Donato L; Sheldon C; Keyhani A; Satterwhite C; Yu M; Fiscella M; Hulse J; Lin ZJ; Garofolo W; Savoie N; Xiao YQ; Kurylak K; Harris S; Saxena M; Buonarati M; Lévesque A; Boudreau N; Lin J; Khan MU; Ray G; Liu Y; Xu A; Soni G; Ward I; Kingsley C; Ritzén H; Tabler E; Nicholson B; Bennett P; van de Merbel N; Karnik S; Bouhajib M; Wieling J; Mulvana D; Ingelse B; Allen M; Malone M; Fang X
    Bioanalysis; 2016 Mar; 8(6):487-95. PubMed ID: 26916197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.